Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2015 02:33 ET | Source: BioPorto A/S

Interim financial report for Q3 2015 – the BioPorto Group

Submission of application to the FDA and successful rights issue In September, following satisfactory clinical studies at leading hospitals in the US, BioPorto submitted a registration...
November 06, 2015 02:33 ET | Source: BioPorto A/S

Delårsrapport for de første ni måneder af 2015 for BioPorto koncernen

Indsendelse af ansøgning til FDA og succesfuld aktieemission BioPorto har i september, efter tilfredsstillende kliniske studier på førende hospitaler i USA, indsendt registreringsansøgning til...
September 30, 2015 03:00 ET | Source: BioPorto A/S

Aktiekapital og stemmerettigheder

I henhold til § 6 i bekendtgørelse nr. 1442 af 13. december 2013 om udstederes oplysningsforpligtelser bekendtgøres det hermed, at BioPorto A/S' samlede aktiekapital udgør kr. 129.598.960...
September 30, 2015 03:00 ET | Source: BioPorto A/S

Share Capital and Votes

Under Act 6 in executive order no. 1442 dated December 13, 2013 on reporting obligations, BioPorto A/S hereby announces that the company’s total share capital amounts to DKK 129,598,960 divided into...
September 25, 2015 02:41 ET | Source: BioPorto A/S

Indsendelse af ansøgning vedrørende The NGAL TestTM til FDA

BioPorto har i dag indsendt registreringsansøgningen til de amerikanske sundhedsmyndigheder, FDA, om godkendelse af The NGAL TestTM som forventet, jf. selskabsmeddelelse nr. 13 af 3. juli 2015....
September 25, 2015 02:41 ET | Source: BioPorto A/S

Submission of FDA application for The NGAL Test™

Today, BioPorto has submitted a registration application to the US Food and Drug Administration, FDA, for approval of The NGAL Test™, cf. company announcement no. 13 of July 3, 2015. The submission...
September 04, 2015 09:15 ET | Source: BioPorto A/S

Gennemførelse af rettet emission og kapitalforhøjelse

Bestyrelsen for BioPorto A/S (BioPorto) besluttede den 31. august 2015 delvist at udnytte bemyndigelsen i selskabets vedtægter § 16b til at foretage en kontant rettet emission til et begrænset antal...
September 04, 2015 09:15 ET | Source: BioPorto A/S

Completion of rights issue and capital increase

August 31, 2015, The Board of Directors of BioPorto A/S (BioPorto) decided to partially exercise the authorization in the Company Articles article 16b to make a direct placement to a limited...
August 31, 2015 09:38 ET | Source: BioPorto A/S

Storaktionærmeddelelse

BioPorto har d.d. modtaget meddelelse om, at Media Invest Danmark A/S ejer 10% af aktiekapitalen og stemmerne i BioPorto A/S. For yderligere information kontakt: Christina Thomsen,...
August 31, 2015 09:38 ET | Source: BioPorto A/S

Announcement from major shareholder

Today, BioPorto has received notice that Media Invest Danmark A/S holds shares equivalent to 10 % of the share capital and votes in BioPorto A/S. For further information, please...